MPLT Competitors & Alternatives

Compare MapLight Therapeutics, Inc. Common Stock with similar stocks in the same industry

Biotechnology

MPLT

Main Stock
$6.94
-4.28%
Tradestie Score
50
Analyst Upside
+282.4%

Supply-Chain & Ecosystem Map (Customers, Suppliers & Direct Competitors)

Bottleneck Score: 1/10 Other
Competitive Moat: None
Major Customers 0
Diversified enterprise & commercial customer base.
Critical Suppliers 0
Internal vertical integration & multi-sourced components.
Direct Ecosystem Rivals 0
Sole-source / monopoly positioning in sub-sector.

Top Competitors

218 stocks in Biotechnology
Company Price Market Cap P/E Score Action
ATXS Astria Therapeutics, Inc. Common Stock
$12.58
+0.64%
$425.52M - 54 Compare
ALMS Alumis Inc. Common Stock
$5.06
-9.65%
$422.50M - 43 Compare
FDMT 4D Molecular Therapeutics, Inc. Common Stock
$11.65
-4.74%
$407.71M - 52 Compare
DSGN Design Therapeutics, Inc. Common Stock
$9.94
-5.06%
$386.68M - 49 Compare
AURA Aura Biosciences, Inc. Common Stock
$7.21
+1.41%
$382.04M - 31 Compare
DRTS Alpha Tau Medical Ltd. Ordinary Shares
$12.09
-9.64%
$371.64M - 50 Compare
CAPR Capricor Therapeutics Inc
$8.47
-11.12%
$357.51M - 28 Compare
DMAC DiaMedica Therapeutics Inc. Common Stock
$8.42
-4.27%
$354.59M - 48 Compare
CGEM Cullinan Therapeutics, Inc. Common Stock
$9.72
-5.45%
$354.45M - 47 Compare
LBRX LB Pharmaceuticals Inc Common Stock
$42.85
-0.37%
$353.70M - 36 Compare

Data updated: Nov 16, 2026 | Industry: Biotechnology (SIC None)

218 stocks in this industry